Furthermore, within this cohort of 66 EGFR mutated NSCLC patients, the expression of β‐catenin exhibited a positive correlation with MET expression (Figure 2C), and samples with elevated MET expression displayed heightened levels of β‐catenin (Figure 2D). The gene discussed is MET; the disease is non-small cell lung carcinoma.